JP2005505582A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005505582A5 JP2005505582A5 JP2003532054A JP2003532054A JP2005505582A5 JP 2005505582 A5 JP2005505582 A5 JP 2005505582A5 JP 2003532054 A JP2003532054 A JP 2003532054A JP 2003532054 A JP2003532054 A JP 2003532054A JP 2005505582 A5 JP2005505582 A5 JP 2005505582A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- monoclonal antibody
- antibody
- hbv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 25
- 239000003443 antiviral agent Substances 0.000 claims 8
- 208000002672 hepatitis B Diseases 0.000 claims 7
- 208000015181 infectious disease Diseases 0.000 claims 6
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 claims 4
- 229960001627 lamivudine Drugs 0.000 claims 4
- 238000011282 treatment Methods 0.000 claims 4
- 229940123014 DNA polymerase inhibitor Drugs 0.000 claims 2
- 102000014150 Interferons Human genes 0.000 claims 2
- 108010050904 Interferons Proteins 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 239000000039 congener Substances 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 229940079322 interferon Drugs 0.000 claims 2
- 210000004185 liver Anatomy 0.000 claims 2
- 239000002777 nucleoside Substances 0.000 claims 2
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 229940021747 therapeutic vaccine Drugs 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
- 230000003442 weekly effect Effects 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IL2001/000927 WO2003028722A1 (en) | 2001-10-04 | 2001-10-04 | Treatment of hepatitis b virus infection with human monoclonal antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005505582A JP2005505582A (ja) | 2005-02-24 |
| JP2005505582A5 true JP2005505582A5 (uk) | 2005-11-17 |
Family
ID=11043099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003532054A Pending JP2005505582A (ja) | 2001-10-04 | 2001-10-04 | ヒトモノクロナール抗体によるｂ型肝炎ウイルス感染の治療 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1432418A1 (uk) |
| JP (1) | JP2005505582A (uk) |
| KR (1) | KR20040048935A (uk) |
| CN (1) | CN1558763A (uk) |
| CA (1) | CA2462427A1 (uk) |
| IL (1) | IL161138A0 (uk) |
| WO (1) | WO2003028722A1 (uk) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9292111B2 (en) | 1998-01-26 | 2016-03-22 | Apple Inc. | Gesturing with a multipoint sensing device |
| US8479122B2 (en) | 2004-07-30 | 2013-07-02 | Apple Inc. | Gestures for touch sensitive input devices |
| RU2275921C2 (ru) * | 2004-02-04 | 2006-05-10 | Роман Геннадиевич Мязин | Способ лечения хронических диффузных заболеваний печени применением курса внутривенных инфузий растворов гипохлорита натрия |
| WO2006076640A1 (en) * | 2005-01-14 | 2006-07-20 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Monoclonal antibodies that bind or neutralize hepatitis b virus |
| KR101280273B1 (ko) * | 2005-04-18 | 2013-07-15 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | 안정화된 항-ｂ형 간염 바이러스 (ｈｂｖ) 항체 제형 |
| KR20090056537A (ko) * | 2007-11-30 | 2009-06-03 | 주식회사 녹십자 | Ｂ형 간염 바이러스 중화능을 갖는 항체를 유효성분으로포함하는 ｂ형 간염 바이러스 감염의 예방 또는 치료용조성물 |
| CN102757492A (zh) * | 2011-04-26 | 2012-10-31 | 中国人民解放军第二军医大学 | 全人乙肝表面蛋白单克隆抗体及其在制备预防hbv感染药物中的用途 |
| KR101771309B1 (ko) * | 2015-07-24 | 2017-08-24 | 재단법인 목암생명과학연구소 | B형 간염 바이러스의 ｃｃｃＤＮＡ 형성 억제용 약학 조성물 |
| CN105001325A (zh) * | 2015-07-31 | 2015-10-28 | 北京泰诺迪生物科技有限公司 | 一种全人源抗乙肝病毒中和抗体及其制备方法与应用 |
| WO2017114812A1 (en) * | 2015-12-29 | 2017-07-06 | F. Hoffmann-La Roche Ag | Combination therapy of an hbsag inhibitor and an interferon |
| US11219646B2 (en) * | 2016-09-30 | 2022-01-11 | Baylor College Of Medicine | Chimeric antigen receptor therapy with reduced cytotoxicity for viral disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL118626A0 (en) * | 1996-06-11 | 1996-10-16 | Xtl Biopharmaceuticals Limited | Anti HBV antibody |
| IL118625A0 (en) * | 1996-06-11 | 1996-10-16 | Xtl Biopharmaceuticals Limited | Anti HBV antibodies |
| EP0893124A1 (de) * | 1997-07-24 | 1999-01-27 | Roche Diagnostics GmbH | Pharmzeutische Kombinationspräparate enthaltend humane monoklonale Antikörper zur Behandlung der chronischen Hepatitis B und eine Virostatisch wirksame Substanz |
-
2001
- 2001-10-04 KR KR10-2004-7004987A patent/KR20040048935A/ko not_active Ceased
- 2001-10-04 IL IL16113801A patent/IL161138A0/xx unknown
- 2001-10-04 CN CNA018236928A patent/CN1558763A/zh active Pending
- 2001-10-04 JP JP2003532054A patent/JP2005505582A/ja active Pending
- 2001-10-04 WO PCT/IL2001/000927 patent/WO2003028722A1/en not_active Application Discontinuation
- 2001-10-04 EP EP01978778A patent/EP1432418A1/en not_active Withdrawn
- 2001-10-04 CA CA002462427A patent/CA2462427A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2329050C2 (ru) | Комбинация ингибиторов цитохром-р450-зависимых протеаз | |
| RU2007105354A (ru) | Применение комбинации циклоспорина и пэгилированного интерферона для лечения гепатита с (hcv) | |
| Cheng et al. | Clinical effects of NTCP‐inhibitor myrcludex B | |
| RU2003131876A (ru) | Композиции n-ацетилцистеина и способы лечения и профилактики токсичности лекарственных средств | |
| RU2007132181A (ru) | ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ | |
| RU2004106569A (ru) | Способ применения антибиотиков | |
| TWI317735B (en) | Methods and compositions for treating hepatitis c virus | |
| HUP0003131A2 (hu) | Polietilénglikol/alfa-interferon konjugátumok fertőzés kezelésére | |
| TW200412960A (en) | Potent inhibitor of HCV serine protease | |
| EA200701869A1 (ru) | Пептидомиметические ингибиторы протеазы | |
| JP2005505582A5 (uk) | ||
| RU2013148779A (ru) | Лечение инфекции вируса гепатита в по отдельности или в комбинации с вирусом гепатита дельта и родственных заболеваний печени | |
| JP2006513184A5 (uk) | ||
| RU2010126598A (ru) | Применение человеческого антитела, способного нейтрализовать вирус гепатита в, для профилактики или лечения инфекции вирусом гепатита в | |
| JP2017514911A5 (uk) | ||
| Chave et al. | Henoch‐Schönlein purpura following hepatitis B vaccination | |
| KR970705563A (ko) | 항바이러스제로서의 4-(2-아미노-6-(시클로프로필아미노)-9H-푸린-9-일)-2-시클로펜텐-1-메탄올 숙시네이트(4-(2-Amino-6-(Cyclopropylamino)-9H-Purin-9-yl)-2-Cyclopentene-1-Methanol Succinate as Antiviral Agent) | |
| AR022116A1 (es) | Terapia de combinacion para el vhc por induccion de ribavirina - interferon alfa | |
| WO2006044968A3 (en) | Combination therapy for treating viral infections | |
| RU2007104774A (ru) | Комбинация анти-вич ингибиторов обратной транскриптазы и протеазы | |
| RU2002105485A (ru) | Применение микофенолята мофетила в сочетании с ПЭГ-интерфероном-α (ПЭГ-IFN-α) | |
| JP2007501806A5 (uk) | ||
| EA202100186A2 (ru) | Вакцина и способ защиты от коронавирусной инфекции | |
| JP2005505582A (ja) | ヒトモノクロナール抗体によるｂ型肝炎ウイルス感染の治療 | |
| RU2013120345A (ru) | Новые способы лечения инфекции, вызванной вирусом гепатита с |